As part of the QUAMED team, the delegation from the DRC participated in the 2024 QUAMED General Assembly, along with Prosper Hiag, one of our members and the vice-president of the FIP.
GA Day 2 Highlights: Insights from Joanna Darmanin and Dirk Brems on Medicine Access
The second day of the 2024 QUAMED General Assembly was opened by Joanna Darmanin from DG ECHO and Dirk Brems from DGD. We were happy to hear about their continuing commitment to equitable access to quality medicines. DGD has been instrumental in the conception and development of QUAMED as a network and as an association. ...
Quamed’s GA Highlights: QCP GSDP Certificate
The first day of the QUAMED 2024 General Assembly was successfully concluded with a brief ceremony to hand over the QCP GSDP certificate to SALAMA Centrale d’Achats de Médicaments Essentiels, the central medical store of Madagascar. The President of QUAMED, Patrick Lukulay, Ph.D., presented the certificate in person to Director General Mieja Rakotonarivo in the ...
Highlights from the Quamed General Assembly: Introducing the Quamed Learning Platform!
Exciting times at the Quamed General Assembly! Today, Chantal Kayitesi presented our latest innovation, the Quamed Learning platform. This powerful Learning Management System is designed to help you enhance your expertise in medical products quality assurance. Dive into engaging content, connect with peers, access essential documentation, and get your technical questions answered by experts in ...
WHO Issues Urgent Alert on Falsified OZEMPIC in Brazil, UK, and USA
The World Health Organization (WHO) has issued an urgent alert about falsified OZEMPIC (semaglutide) detected in Brazil, the UK, and the USA. These counterfeit products pose significant health risks, including ineffective treatment and potential contamination. Identified batches include LP6F832, NAR0074 with serial number 430834149057, and falsified versions of genuine batch MP5E511. The public is advised ...
QUAMED and Relief International Launch Project to Improve Medicine Access
We are delighted to announce that QUAMED has signed a contract with Relief International to run an exciting 4-year project: “Improving Access to Quality Medicines and Medical Supplies in Fragile and Conflict-Affected Countries”. The project will focus on building the capacity of 20 local medical product suppliers across Afghanistan, Yemen, Myanmar, and Syria. Following market ...
Congratulations to MCAZ for Achieving WHO Maturity Level 3
We would like to congratulate the MCAZ on becoming the 6th country in Africa to achieve WHO maturity level 3. We are indirectly profiting from their expertise as our colleague Linda Mudyiwenyama was part of the MCAZ team up to two years ago. Linda is currently collaborating with the Rwanda FDA in their quest to ...
New Framework to Improve Access to Medicines and Healthcare Outcomes
Excited to share a new analytical framework for evaluating access to medicines from a health systems perspective! Developed from a study on childhood oncology medicines in South Africa, this framework focuses on eight key pharmaceutical processes to identify barriers and facilitators to access. Targeting national processes guides effective policy development to improve healthcare outcomes. #HealthSystems ...
Gaps in Access to Reproductive Medicines in Eastern Mediterranean
A recent study assessed access to mifepristone, misoprostol, and contraceptive medicines in eight Eastern Mediterranean countries, highlighting significant gaps. Despite their critical role in reducing maternal mortality, most countries did not include all WHO essential contraceptives in national guidelines. Only Lebanon and Pakistan had comprehensive family planning guidelines, and only Afghanistan and Lebanon included mifepristone ...
Job Alert: Regulatory Expert
QUAMED (www.quamed.org) is a not-for-profit organisation specialising in various aspects of pharmaceutical quality assurance. We conduct pharmaceutical assessments and audits, develop and facilitate training courses around pharmaceutical quality, auditing and inspection and organise and provide technical assistance in the field of pharmaceutical quality assurance. We are starting a new project in Senegal with as objective ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.